Titre : Capacité vitale

Capacité vitale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Blood Transfusion
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Capacité vitale : Questions médicales les plus fréquentes", "headline": "Capacité vitale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Capacité vitale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-22", "dateModified": "2025-04-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Capacité vitale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Capacité pulmonaire totale", "url": "https://questionsmedicales.fr/mesh/D014109", "about": { "@type": "MedicalCondition", "name": "Capacité pulmonaire totale", "code": { "@type": "MedicalCode", "code": "D014109", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Volume de réserve expiratoire", "alternateName": "Expiratory Reserve Volume", "url": "https://questionsmedicales.fr/mesh/D005105", "about": { "@type": "MedicalCondition", "name": "Volume de réserve expiratoire", "code": { "@type": "MedicalCode", "code": "D005105", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850.970.360" } } }, { "@type": "MedicalWebPage", "name": "Capacité inspiratoire", "alternateName": "Inspiratory Capacity", "url": "https://questionsmedicales.fr/mesh/D007320", "about": { "@type": "MedicalCondition", "name": "Capacité inspiratoire", "code": { "@type": "MedicalCode", "code": "D007320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850.970.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Volume de réserve inspiratoire", "alternateName": "Inspiratory Reserve Volume", "url": "https://questionsmedicales.fr/mesh/D007321", "about": { "@type": "MedicalCondition", "name": "Volume de réserve inspiratoire", "code": { "@type": "MedicalCode", "code": "D007321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850.970.500.375" } } }, { "@type": "MedicalWebPage", "name": "Volume courant", "alternateName": "Tidal Volume", "url": "https://questionsmedicales.fr/mesh/D013990", "about": { "@type": "MedicalCondition", "name": "Volume courant", "code": { "@type": "MedicalCode", "code": "D013990", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850.970.500.700" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Capacité vitale", "alternateName": "Vital Capacity", "code": { "@type": "MedicalCode", "code": "D014797", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Toby M Maher", "url": "https://questionsmedicales.fr/author/Toby%20M%20Maher", "affiliation": { "@type": "Organization", "name": "Keck School of Medicine, University of Southern California, Los Angeles, California, USA." } }, { "@type": "Person", "name": "Hyun Lee", "url": "https://questionsmedicales.fr/author/Hyun%20Lee", "affiliation": { "@type": "Organization", "name": "Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea." } }, { "@type": "Person", "name": "Hye Yun Park", "url": "https://questionsmedicales.fr/author/Hye%20Yun%20Park", "affiliation": { "@type": "Organization", "name": "Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea." } }, { "@type": "Person", "name": "Masato Kono", "url": "https://questionsmedicales.fr/author/Masato%20Kono", "affiliation": { "@type": "Organization", "name": "Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. Electronic address: masato.k@sis.seirei.or.jp." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Blood transfusion in pediatric intracranial tumor surgery.", "datePublished": "2024-10-14", "url": "https://questionsmedicales.fr/article/39402508", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12871-024-02748-7" } }, { "@type": "ScholarlyArticle", "name": "Blood transfusion and the presence of biological structures in the circulation.", "datePublished": "2022-09-30", "url": "https://questionsmedicales.fr/article/37114279", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.14715/cmb/2022.68.10.1" } }, { "@type": "ScholarlyArticle", "name": "Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias.", "datePublished": "2023-01-13", "url": "https://questionsmedicales.fr/article/36637054", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD013767.pub2" } }, { "@type": "ScholarlyArticle", "name": "The characteristics of blood transfusion and analysis of preoperative factors associated with intraoperative blood transfusion in congenital heart surgery: a case-control study.", "datePublished": "2022-12-24", "url": "https://questionsmedicales.fr/article/36566199", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13019-022-02068-2" } }, { "@type": "ScholarlyArticle", "name": "Autologous blood transfusion reduces the requirement for perioperative allogenic blood transfusion in patients undergoing major hepatopancreatobiliary surgery: a retrospective cohort study.", "datePublished": "2023-10-01", "url": "https://questionsmedicales.fr/article/37402308", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/JS9.0000000000000557" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes physiologiques respiratoires et circulatoires", "item": "https://questionsmedicales.fr/mesh/D002943" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes physiologiques respiratoires", "item": "https://questionsmedicales.fr/mesh/D012143" }, { "@type": "ListItem", "position": 4, "name": "Capacité pulmonaire totale", "item": "https://questionsmedicales.fr/mesh/D014109" }, { "@type": "ListItem", "position": 5, "name": "Capacité vitale", "item": "https://questionsmedicales.fr/mesh/D014797" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Capacité vitale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Capacité vitale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Capacité vitale", "description": "Comment évaluer la capacité vitale ?\nQuels tests complètent l'évaluation ?\nQuels sont les critères normaux de capacité vitale ?\nQuand suspecter une capacité vitale réduite ?\nQuels signes indiquent un problème pulmonaire ?", "url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Blood+Transfusion&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Capacité vitale", "description": "Quels symptômes sont liés à une capacité vitale faible ?\nLa toux est-elle un symptôme associé ?\nComment la fatigue se manifeste-t-elle ?\nY a-t-il des signes d'alerte ?\nLes symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Blood+Transfusion&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Capacité vitale", "description": "Comment prévenir la réduction de la capacité vitale ?\nLes vaccinations sont-elles importantes ?\nQuel rôle joue l'exercice physique ?\nFaut-il éviter certaines expositions ?\nL'hydratation est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Blood+Transfusion&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Capacité vitale", "description": "Quels traitements améliorent la capacité vitale ?\nLa physiothérapie est-elle utile ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une intervention chirurgicale ?\nLes traitements varient-ils selon la cause ?", "url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Blood+Transfusion&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Capacité vitale", "description": "Quelles complications peuvent survenir ?\nLa capacité vitale faible augmente-t-elle les risques ?\nLes maladies cardiaques sont-elles liées ?\nComment les infections affectent-elles la capacité vitale ?\nY a-t-il des effets à long terme ?", "url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Blood+Transfusion&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Capacité vitale", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il la capacité vitale ?\nLes maladies chroniques sont-elles un facteur ?\nLe sexe joue-t-il un rôle ?\nL'environnement de travail est-il un facteur ?", "url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Blood+Transfusion&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la capacité vitale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La capacité vitale est mesurée par spirométrie, un test de la fonction pulmonaire." } }, { "@type": "Question", "name": "Quels tests complètent l'évaluation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme la pléthysmographie et les gaz du sang peuvent être utilisés." } }, { "@type": "Question", "name": "Quels sont les critères normaux de capacité vitale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les valeurs normales varient selon l'âge, le sexe et la taille, généralement entre 3 et 6 L." } }, { "@type": "Question", "name": "Quand suspecter une capacité vitale réduite ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une capacité vitale réduite est suspectée en cas de dyspnée ou d'antécédents de maladies pulmonaires." } }, { "@type": "Question", "name": "Quels signes indiquent un problème pulmonaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la toux persistante ou la fatigue peuvent indiquer une capacité vitale altérée." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une capacité vitale faible ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent essoufflement, fatigue, et sensation d'oppression thoracique." } }, { "@type": "Question", "name": "La toux est-elle un symptôme associé ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une toux persistante peut accompagner une capacité vitale diminuée." } }, { "@type": "Question", "name": "Comment la fatigue se manifeste-t-elle ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "La fatigue peut se manifester par une diminution de l'énergie et des difficultés à l'effort." } }, { "@type": "Question", "name": "Y a-t-il des signes d'alerte ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des douleurs thoraciques ou une cyanose nécessitent une attention médicale immédiate." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de la dégradation pulmonaire." } }, { "@type": "Question", "name": "Comment prévenir la réduction de la capacité vitale ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme, pratiquer une activité physique régulière et avoir une alimentation équilibrée." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccins contre la grippe et le pneumocoque aident à prévenir les infections respiratoires." } }, { "@type": "Question", "name": "Quel rôle joue l'exercice physique ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier améliore la fonction pulmonaire et la capacité vitale." } }, { "@type": "Question", "name": "Faut-il éviter certaines expositions ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, éviter les polluants et les allergènes peut aider à préserver la santé pulmonaire." } }, { "@type": "Question", "name": "L'hydratation est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hydratation aide à maintenir la santé des voies respiratoires." } }, { "@type": "Question", "name": "Quels traitements améliorent la capacité vitale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la réhabilitation pulmonaire, les bronchodilatateurs et les corticostéroïdes." } }, { "@type": "Question", "name": "La physiothérapie est-elle utile ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie respiratoire aide à améliorer la capacité vitale et la fonction pulmonaire." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les bronchodilatateurs peuvent aider à ouvrir les voies respiratoires." } }, { "@type": "Question", "name": "Quand envisager une intervention chirurgicale ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une chirurgie peut être envisagée en cas de maladies pulmonaires graves, comme la BPCO." } }, { "@type": "Question", "name": "Les traitements varient-ils selon la cause ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le traitement dépend de la cause sous-jacente de la réduction de la capacité vitale." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent l'insuffisance respiratoire et des infections pulmonaires." } }, { "@type": "Question", "name": "La capacité vitale faible augmente-t-elle les risques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une capacité vitale faible augmente le risque de complications respiratoires graves." } }, { "@type": "Question", "name": "Les maladies cardiaques sont-elles liées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une capacité vitale réduite peut être associée à un risque accru de maladies cardiaques." } }, { "@type": "Question", "name": "Comment les infections affectent-elles la capacité vitale ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les infections pulmonaires peuvent réduire la capacité vitale en provoquant une inflammation." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une capacité vitale réduite peut entraîner des effets à long terme sur la santé respiratoire." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent le tabagisme, l'exposition à des polluants et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il la capacité vitale ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la capacité vitale diminue généralement avec l'âge en raison de la dégradation pulmonaire." } }, { "@type": "Question", "name": "Les maladies chroniques sont-elles un facteur ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de capacité vitale réduite." } }, { "@type": "Question", "name": "Le sexe joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les hommes ont généralement une capacité vitale plus élevée que les femmes en moyenne." } }, { "@type": "Question", "name": "L'environnement de travail est-il un facteur ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, travailler dans des environnements pollués ou dangereux peut affecter la capacité vitale." } } ] } ] }

Sources (10000 au total)

Blood transfusion in pediatric intracranial tumor surgery.

Pediatric central nervous system tumors are the most common solid tumors in children and leading cause of cancer-related morbidity and mortality. Various factors may influence the practice of blood tr... A retrospective study was performed in all pediatric patients younger than 15 years who underwent craniotomy for brain tumor removal from January 2018 to December 2023 in our institution. Preoperative... A total of 138 patients were enrolled in the study, of whom 62 (44.9%) required intraoperative blood transfusion. In multivariate regression analysis age < 4 years and operating time > 490 min were de... In conclusion, the findings obtained in this study suggest that age and surgical duration are independent risk factors for intraoperative blood transfusion in pediatric patients undergoing surgery for...

Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias.

Non-transfusion-dependent β-thalassaemia (NTDβT) is a subset of inherited haemoglobin disorders characterised by reduced production of the β-globin chain of haemoglobin leading to anaemia of varying s... To compare the effectiveness and safety of the following for reducing blood transfusion for people with NTDβT: 1. HbF inducers versus usual care or placebo; 2. single HbF inducer with another HbF indu... We used standard, extensive Cochrane search methods. The latest search date was 21 August 2022.... We included randomised controlled trials (RCTs) or quasi-RCTs comparing single HbF inducer with placebo or usual care, with another single HbF inducer or with a combination of HbF inducers; or compari... We used standard Cochrane methods. Our primary outcomes were blood transfusion and haemoglobin levels. Our secondary outcomes were HbF levels, the long-term sequelae of NTDβT, quality of life and adve... We included seven RCTs involving 291 people with NTDβT, aged two to 49 years, from five countries. We reported 10 comparisons using eight different HbF inducers (four pharmacological and four natural)... We are uncertain whether any of the eight HbF inducers in this review have a beneficial effect on people with NTDβT. For each of these HbF inducers, we found only one or at the most two small studies....

The characteristics of blood transfusion and analysis of preoperative factors associated with intraoperative blood transfusion in congenital heart surgery: a case-control study.

Blood transfusion is a common and life-saving procedure in congenital heart surgery (CHS), and it is critical for patients to identify risk factors prior to surgery. Our objective is to conduct an ana... A total of 1550 cases were retrospectively analyzed in our institution between May 2019 and June 2020. We determined whether to employ red blood cells (RBCs), platelets, and plasma as dependent variab... The total amounts of transfused RBCs, platelets, and plasma were 850.5 U (N = 713, 46%), 159 U (N = 21, 1.4%), and 1374.2 U (N = 953, 61.5%), respectively. Multivariate analysis found age (OR 0.142, 9... Although patients' age, weight, routine blood test, coagulation function, and protein levels should all be considered for preparing blood before CHS, the RACHS method is the most important factor infl...

Autologous blood transfusion reduces the requirement for perioperative allogenic blood transfusion in patients undergoing major hepatopancreatobiliary surgery: a retrospective cohort study.

Major hepatopancreatobiliary surgery is associated with a risk of major blood loss. The authors aimed to assess whether autologous transfusion of blood salvaged intraoperatively reduces the requiremen... In this single centre study, information from a prospective database of 501 patients undergoing major hepatopancreatobiliary resection (2015-2022) was analysed. Patients who received cell salvage ( n ... 32% of the lost blood volume was replaced through autologous transfusion in patients receiving cell salvage. Although the cell salvage group experienced significantly higher intraoperative blood loss ... Cell salvage use was associated with a reduction in allogenic blood transfusion and a reduction in 30-day mortality in patients undergoing major hepatectomy. Prospective trials are warranted to unders...

Effect of cell salvage on bleeding, transfusion of blood products, and bleeding parameters in patients undergoing liver transplantation with intraoperative massive blood transfusion.

Autologous transfusion using a cell saver system has been used in liver transplantation with controversial outcomes. Its efficiency in patients with massive intraoperative transfusion has not been stu... Consecutive patients aged ≥18 years with intraoperative massive blood transfusion (≥ 6 units) between March 2014 and September 2020 were included. Patients subjected to CS were grouped as CS, whereas ... There were 38 and 32 patients in CS and control groups, respectively. Median blood loss was significantly lower in CS group than in control group (2500 mL vs. 4000 mL, p = 0.010). There were significa... Use of CS in patients undergoing liver transplantation with massive intraoperative transfusion did not improve clinical and transfusion-related outcomes. In conclusion, its usage can be questionable g...

Patient and caregiver perceptions of the possibility of home blood transfusions.

Patients with hematologic malignancies (HM) often develop transfusion dependence. The patient and caregiver burdens associated with the need for frequent transfusions are high. Home blood transfusions... Eligible patients included Adult (≥18 years) patients who were English speaking and met the definition for transfusion dependence within 3 months of study enrollment. We identified and interviewed eli... We recruited participants until we reached thematic saturation, which occurred at 29 participants (20 patients, 9 caregivers). Among the 20 patient participants, nine had MDS (45%) and 11 had acute le... The concept of home blood transfusions was well received and further research to study its implementation is warranted....

Perioperative Blood Transfusion in Head and Neck Cancer Revisited.

To reevaluate the frequency of perioperative blood transfusion, transfusion triggers, and survival impact in patients with incident, surgically treated head and neck cancer (HNC) in restrictive transf... Retrospective analysis of surgically treated patients with incident HNC with and without perioperative blood transfusion between 2008 and 2019 at the Department of Otorhinolaryngology, Head and Neck S... Of the 590 patients included, perioperative transfusions were administered in 6.3% (n = 37, transfusion group). Following multivariable logistic regression, likelihood of blood transfusions was increa... Considering current restrictive transfusion regimens and general transfusion risks, the administration of blood products in HNC patients during the perioperative period is not associated with addition... 3 Laryngoscope, 133:1638-1644, 2023....